INTRODUCTION
Pakistan is ranked 8 th in terms of estimated number of Tuberculosis cases by WHO in 22 high burden countries. 1 Almost 1.5 million people suffer from Tuberculosis in this country of 144 million population indicating a prevalence exceeding 1% of the total population. Global tuberculosis report by WHO mentions the case notification rate for Pakistan as 23/100,000 in the year 2001. 3 Tuberculosis has become an important public health problem in today's world whereas previously it was considered a nuisance associated usually with the developing countries. 4 A recent increase in tuberculosis incidence and complications has been registered in connection with the spread of antibiotic resistance and AIDS. 5 The diagnosis of mycobacterial disease depends upon identifying the infective organism in secretion or tissues of diseased individual. There are several limitations of this method of diagnosis. 6 The rapid detection and identification of Mycobacterium Tuberculosis complex in samples are extremely important for optional diagnosis, and effective treatment as well as for prevention and control of tuberculosis transmission. 7 Sero-diagnostic tests based on the presence of antibodies against mycobacterial antigens in the sera have been identified, purified and tested, with various degrees of success. 8 The present
study was designed to demonstrate and evaluate A-60 specific IgG antibody levels in the sera for the rapid diagnosis of different clinical forms of tuberculosis. The control group (136 subjects) was classified into the following categories: 1. Tuberculosis negative healthy subjects (15 subjects). They were included into this group according to negative response to intra-dermal injection of 51 U of PPD. A diameter of induration less than 10 mm after 72 hours was considered as negative test. 2. Tuberculosis positive healthy subjects (9 subjects). They were included into this group according to positive response to intra-dermal injections of 5I U of PPD. A diameter of induration of >10mm after 72 hours was considered as positive test. 3. Non-tuberculosis patients with pulmonary pathology (15 subjects). They included 3 cases of lung abscess, 2 cases of COPD, 3 cases of bronchogenic carcinoma and one case of each chronic bronchitis, hydro-pneumothorax, nephritic syndrome with pleural effusion and easinophylic pneumonia. 4. Non-tuberculosis patients with extra pulmonary pathology (7 subjects). They included 5 cases of cervical lymph-adenopathy and one case of each nephritic syndrome and thyroid benign pathology. 5. Contact cases of tuberculosis (36 subjects). Thy included members of the staff serving in the wards like doctors, nurses, ward-boys, ayahs, dieticians, waiters, dressers, liftmen, sweepers etc. 6. Subjects handling mycobacteria (54 subjects).
MATERIAL AND METHODS
They included technicians from different laboratories in the town.
Laboratory Procedures:
Specimens of blood were taken with appropriate consent. Five ml of blood was drawn from superficial vein from each subject with the help of disposable syringe under aseptic conditions. It was transferred to a sterile cup and allowed to clot at room temperature. Then it was centrifuged and serum was separated and transferred with the help of disposable Pasteur pipette to a sterile cup and stored in a refrigerator at -20 o C until processed for analysis. In the present study the measurement of IgG antibodies against A 60, strain BCG of M. bovis was done in serum of our study population with an ELISA KIT (Anda TB Biological, Strasbourg, France). Stored serum samples of our study population were taken out from the freezer one-hour prior to the test. Anti A60 IgG were estimated in the sera of the subjects under study employing indirect ELISA technique as per recommendations of the manufacturer. Each time the positive as well as the negative reference sera provided with diagnostic kit were included in the test along with the test sera. For IgG determination, the curves were constructed by plotting the optical density values of different reference curve.
Principle of Method:
Anda TB is an immune-enzymatic test with dosage on a solid phase. Sample of human sera is distributed in the wells of micro-titration plate coated with the A60 mycobacterium complexes. Their incubation allows the formations of antigen-antibody complexes. Washing eliminates the unloading components of the sera. The wells are thereafter incubated with peroxides labeled antihuman IgG antibodies that bind to the antibody complexes present. The unbound components are eliminated by washing. The peroxidase substrate, tetra-methyl benzidine (TMB) containing hydrogen peroxide, is thereafter introduced in the wells. A color develops during the reaction of peroxide with TMB, whose intensity is proportional to the quantity of specific antibodies present in the sample.
RESULTS
The present study involved analysis of 205 serum samples for estimation of IgG against antigen A 60 for rapid diagnosis of tuberculosis by ELISA technique from subjects belonging to groups of tuberculosis patients and various control groups. Table III) . The corresponding mean titres for IgG antibodies in control subjects were 0.601 OD for IgG. (Table IV) 
DISCUSSION
The present work was performed to demonstrate and evaluate the IgG antibodies against A60 antigen by ELISA technique for the rapid serological diagnosis of tuberculosis. A cut off point which is essential for the interpretation of serological data, is based on large surveys of controls subjects (healthy persons with no history of a given disease and patients with other diseases) and varies according to environmental conditions. Our approach was to apply the cut off recommended by the manufacturer i.e. IgG absorbance (sero units), negative (<125), dubious (125 -225) and positive (>225). In this study, we estimated IgG against antigen A 60 in control groups and patients from different forms of tuberculosis. The usefulness of studying several control groups consists both in defining the cut off point to use for tuberculous patients from our region and consequently, evaluating the specificity of the test. In the healthy control groups, very few subjects yielded a positive serology against A60 antigen. In tuberculin negative healthy subjects, all were serological negative for IgG class with 100% sero-negative. Whereas, among tuberculin positive healthy subjects, 3 were positive for IgG. In human contacts with cases of tuberculosis, a few subjects showed a positive A60 serology, and only 13.8% were positive for IgG antibodies. In the group of laboratory staff who had been routinely handling the mycobacterial cultures showed surprisingly the low serological positivity. Only 14.8% were positive for IgG antibodies. Earlier reports and sero-positivity against A60 antigen in the control population ranged between 0-50% for IgG antibodies. The IgG levels in the control subjects in this study were appreciably lowered compared to those in case of active and healed tuberculosis. Similar results were observed in India. 9 These findings are more or less in the agreement with earlier reports. [10] [11] [12] In this study, specificity of the tests ranged from 66.6% to 80% in non-tuberculosis pulmonary pathology, but some patients analyzed departed strikingly from this norm and yielded different patterns of sero-positivity. Other authors have also reported similar events.
10,11,13-15 A very good serological response was observed in cases with sputum positive active pulmonary tuberculosis with regard to IgG antibodies depicting a sensitivity of 88.8% and the mean levels of IgG antibodies were appreciably higher than in the controls. In studies carried out earlier, an IgG sensitivity ranging from 48-100% has been documented. 9, 11, 12 These wide variations could be due to different age groups studied, geographical area and severity of disease in different studies as well as variety in cut off limit used. In the present study, relatively low seropositivity was seen in cases of sputum negative active pulmonary tuberculosis compared to those of sputum positive active pulmonary tuberculosis as shown in a previous study. 11 As far as serology in patients with extra pulmonary tuberculosis is concerned, a sensitivity of 47.3% for IgG was observed. The mean antibody levels were lower than the active pulmonary tuberculosis. A few studies done in Western countries have shown 100% sensitivity of IgG in cases of extra pulmonary tuberculosis. 8, 9 In an Indian study, IgG with 73.8% sensitivity was observed in cases of extra pulmonary tuberculosis. Again wide variations were observed which may be due to different clinical type of extra pulmonary tuberculosis, variety in cut off limit used, different age groups studied, and demographic areas as well as severity of diseases in different studies. On analysis of cases of healed tuberculosis (treated) quite a large number was found positive for IgG (62.5%); the results observed in cases of healed tuberculosis are comparable to those documented by previous study. 9 Moreover, the mean antibody levels were also higher than those of control, although the levels were lower than those in active pulmonary tuberculosis. Substantial lowering of anti A60 immunoglobulins observed by different authors is probably due to the varying time between the inclusion in the study and the end of anti-tuberculosis therapy. 15 In this study, detection of anti A60 antibodies in patients with pulmonary and extra pulmonary tuberculosis was negative in a very small percentage of cases. This may be a result of immuno-depression due to disease as well as to the presence of immune complex. 15 In this study, a small percentage of healthy subjects and patients with non-tuberculous disease showed sero-positivity. This might be due to either sub-clinical infection of environmental non-tuberculous mycobacteria that also express A60 or to the presence in the host of commensal non-pathogenic mycobacteria. The deregulation of the humoral immune response that occurs frequently in several diseases might be another cause of positive results in patients with nontuberculous disease. 16 The estimating of IgG antibodies against A60 antigen for rapid diagnosis of pulmonary and extra pulmonary tuberculosis is clear from our data. Considering all the cases of active tuberculosis and the controls the global sensitivity of 69.8% and specificity of 82.4% were obtained when IgG antibodies estimations were taken into account. In India, test sensitivity of 91.6% and specificity of 90% were demonstrated in post primary tuberculosis by estimating A60 specific IgG antibodies. 9 Similar results were observed in France where a test sensitivity of 98.6% and specificity of 86.7% was reported.
11 Sero-diagnostic tests based on the presence of antibodies against mycobacterial antigens in sera have been described with various degrees of success.
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CONCLUSION
The present study has confirmed the value of estimation of anti-tuberculosis antibody IgG against A60 for the rapid diagnosis of tuberculosis. Considering all the cases of active tuberculosis, the global sensitivity of 69.8% and specificity of 8.4% were obtained but the sensitivity in extra-pulmonary tuberculosis was only 43.7%. This test should not be considered to be diagnostic tool by itself. It should be used in conjunction with other diagnostic mean that together allow the determination of a diagnosis.
